This compound is primarily utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). It serves as a key linker component, connecting the E3 ligase ligand to the target protein ligand, enabling the selective degradation of specific proteins within cells. Its application is significant in cancer research, where it helps in the degradation of oncogenic proteins, offering a potential therapeutic strategy. Additionally, it is employed in biochemical studies to investigate protein function and regulation, aiding in the discovery of novel drug targets. The compound's stability and efficiency in forming ternary complexes make it a valuable tool in both academic and pharmaceutical research.